Publications

5539 Results

Chemoprevention of melanoma: theoretical and practical considerations

Authors
MF Demierre;VK Sondak
Journal / Conference
Cancer Control 12(4):219-222
Year
2005
Research Committee(s)
Melanoma

Cutaneous melanoma: pathogenesis and rationale for chemoprevention

Authors
MF Demierre;VK Sondak
Journal / Conference
Critical Reviews in Oncology and Hematology 53(3):225-239
Year
2005
Research Committee(s)
Melanoma

Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma PMID16356309

Authors
A Venook;C Blanke;D Niedzwiecki;HJ Lenz;J Taylor;D Hollis;S Sutherland;R Goldberg
Journal / Conference
Clinical Colorectal Cancer 5(4):292-294
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
CTSU/C80405

Plasma markers of tumor hypoxia-angiogenesis as predictors of therapeutic response

Authors
P Mack;PH Gumerlock;PN Lara;QT Le;JA Longmate;K Chansky;J Crowley;D Gandara
Journal / Conference
Proc Amer Assoc Cancer Res, Vol. 46, abstr #1140
Year
2005
Research Committee(s)
Lung
Study Number(s)
S0003

Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13

Authors
WP Peters;GL Rosner;JJ Vredenburgh;EJ Shpall;M Crump;PG Richardson;MW Schuster;LB Marks;C Cirrincione;L Norton;IC Henderson;RL Schilsky;DD Hurd
Journal / Conference
Journal of Clinical Oncology 23(10):2191-200
Year
2005
Research Committee(s)
Breast
Study Number(s)
SWOG-9114 (INT-0163) (CALGB-9082)

Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741

Authors
T Delaunoit;SR Alberts;DJ Sargent;E Green;R Goldberg;J Krook;C Fuchs;RK Ramanathan;SK Williamson;RF Morton;BP Findlay
Journal / Conference
Annals of Oncology Mar;16(3):425-429
Year
2005
Research Committee(s)
Gastrointestinal
PMC
PMID15677624
Study Number(s)
N9741

A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group study

Authors
RP Whitehead;J Benedetti;JL Abbruzzese;B Ardalan;JW Goodwin;SP Balcerzak;W Samlowski;HJ Lenz;JS Macdonald
Journal / Conference
Investigational New Drugs 22:335-341
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9100

Implementation of the prostate cancer prevention trial (PCPT)

Authors
PJ Goodman;CM Tangen;JJ Crowley;SM Carlin;A Ryan;CA Coltman, Jr.;LG Ford;IM Thompson
Journal / Conference
Controlled Clinical Trials 2:203-222
Year
2004
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group study

Authors
SG Urba;K Chansky;PJ vanVeldhuizen;RE Pluenneke;JK Benedetti;JS Macdonald;JL Abbruzzese
Journal / Conference
Investigational New Drugs 22:91-97
Year
2004
Research Committee(s)
Gastrointestinal
Study Number(s)
S9801

Randomized phase II trial of two high dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study

Authors
PJ Stiff;EJ Shpall;PY Liu;SP Wilczynski;NS Callander;SA Scudder;AR Jazieh;W Samlowski;J McCoy;DS Alberts
Journal / Conference
Gynecologic Oncology 94:98-106
Year
2004
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9106